Trials / Conditions / Metastatic Endometrioid Adenocarcinoma
Metastatic Endometrioid Adenocarcinoma
3 registered clinical trials studyying Metastatic Endometrioid Adenocarcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer NCT04498520 | Pamela Munster | Phase 1 |
| Completed | Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer NCT02728258 | NRG Oncology | Phase 2 |
| Completed | Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer NCT01935934 | National Cancer Institute (NCI) | Phase 2 |